ADA1: Class 04, Study Design and Sampling
Advanced Data Analysis 1, Stat 427/527, Fall 2025
Rubric
Answer each question and specify the supporting evidence.
(6 p) 1. IRS Sampling
In this case study there are two errors in the methodology: one regarding sampling and the other regarding calculation. Focus on the sampling issue.
1. (2 p) Did the paper specify how the sample of 345 returns was selected? If so, identify the sampling method. If not, based on the description and numbers provided, what sampling method do you think might have been used?
Solution:
2. (2 p) What problems with the inferential results might have been introduced by the potential sampling method used?
Solution:
3. (2 p) What sampling method do you suggest for this case? Why?
Solution:
(4 p) 2. Electronic health records (EHR)
Background2: A substantial portion of the US population remains uninsured and even a larger group uses healthcare rarely only. Although the trend is toward greater use of EHRs, only about 40% of patients currently have their information recorded in EHRs.
1. (2 p) Despite the large sample size, why should we be cautious in interpreting the study’s conclusion about hormone replacement therapy? What sampling issue arises from the fact that all participants were nurses, and how might this affect the generalizability of the results to the broader population?
Solution:
*1. (2 p) Can Mary generalize her conclusion to the broader population? Is her estimated proportion of patients with the particular ailment likely too high or too low? Explain why.
Solution:
Footnotes
Kennedy, K., & Bishop, J. (2014). Random sampling issues in a federal court case, a case study. Case Studies In Business, Industry And Government Statistics, 5(2), 111-114. pdf↩︎
Kaplan, Robert M., David A. Chambers, and Russell E. Glasgow. “Big data and large sample size: a cautionary note on the potential for bias.” Clinical and translational science 7.4 (2014): 342-346. pdf↩︎
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med. 1991; 325: 756–762.↩︎